Recombinant Proteins from LifeMap BioReagents
IE users: please get the latest browser version at Microsoft Internet Explorer Home Page
if yot already have the latest browser version please verify that your browser settings is not in compatibility mode
This protocol describes a method to generate endothelial progenitor cells and endothelial cells by exposure of human embryonic stem cells to VEGF. Purified CD31+ cells can be characterized in-vitro and transplanted in-vivo.